
Future Directions for Ustekinumab Biosimilars in Crohn Disease
The authors of a review article on the future of ustekinumab biosimilars for treating Crohn disease (CD) discussed key challenges, including a lack of data in CD and opportunities to improve access to treatment. CD, under the category of inflammatory bowel …